250 related articles for article (PubMed ID: 29486339)
41. Reduced cerebrospinal fluid ethanolamine concentration in major depressive disorder.
Ogawa S; Hattori K; Sasayama D; Yokota Y; Matsumura R; Matsuo J; Ota M; Hori H; Teraishi T; Yoshida S; Noda T; Ohashi Y; Sato H; Higuchi T; Motohashi N; Kunugi H
Sci Rep; 2015 Jan; 5():7796. PubMed ID: 25589364
[TBL] [Abstract][Full Text] [Related]
42. Reduced serum VGF levels were reversed by antidepressant treatment in depressed patients.
Jiang H; Chen S; Lu N; Yue Y; Yin Y; Zhang Y; Jiang W; Liang J; Yuan Y
World J Biol Psychiatry; 2017 Dec; 18(8):586-591. PubMed ID: 28635540
[TBL] [Abstract][Full Text] [Related]
43. Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder.
Ghasemi M; Kazemi MH; Yoosefi A; Ghasemi A; Paragomi P; Amini H; Afzali MH
Psychiatry Res; 2014 Feb; 215(2):355-61. PubMed ID: 24374115
[TBL] [Abstract][Full Text] [Related]
44. Markers of central inflammation in major depressive disorder: A systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue.
Enache D; Pariante CM; Mondelli V
Brain Behav Immun; 2019 Oct; 81():24-40. PubMed ID: 31195092
[TBL] [Abstract][Full Text] [Related]
45. Cerebrospinal fluid neuroplasticity-associated protein levels in patients with psychiatric disorders: a multiplex immunoassay study.
Hidese S; Hattori K; Sasayama D; Tsumagari T; Miyakawa T; Matsumura R; Yokota Y; Ishida I; Matsuo J; Yoshida S; Ota M; Kunugi H
Transl Psychiatry; 2020 May; 10(1):161. PubMed ID: 32439851
[TBL] [Abstract][Full Text] [Related]
46. Isokinetic muscle performance in major depressive disorder: alterations by antidepressant therapy.
Bilici M; Koroglu MA; Cakirbay H; Guler M; Tosun M; Aydin T; Tan U
Int J Neurosci; 2001 Aug; 109(3-4):149-64. PubMed ID: 11699327
[TBL] [Abstract][Full Text] [Related]
47. Early reactions of brain-derived neurotrophic factor in plasma (pBDNF) and outcome to acute antidepressant treatment in patients with Major Depression.
Dreimüller N; Schlicht KF; Wagner S; Peetz D; Borysenko L; Hiemke C; Lieb K; Tadić A
Neuropharmacology; 2012 Jan; 62(1):264-9. PubMed ID: 21803060
[TBL] [Abstract][Full Text] [Related]
48. Serum ghrelin levels and the effects of antidepressants in major depressive disorder and panic disorder.
Ishitobi Y; Kohno K; Kanehisa M; Inoue A; Imanaga J; Maruyama Y; Ninomiya T; Higuma H; Okamoto S; Tanaka Y; Tsuru J; Hanada H; Isogawa K; Akiyoshi J
Neuropsychobiology; 2012; 66(3):185-92. PubMed ID: 22948519
[TBL] [Abstract][Full Text] [Related]
49. Nervonic acid level in cerebrospinal fluid is a candidate biomarker for depressive and manic symptoms: A pilot study.
Kageyama Y; Deguchi Y; Hattori K; Yoshida S; Goto YI; Inoue K; Kato T
Brain Behav; 2021 Apr; 11(4):e02075. PubMed ID: 33599392
[TBL] [Abstract][Full Text] [Related]
50. Prefrontal cortex activation is associated with a discrepancy between self- and observer-rated depression severities of major depressive disorder: a multichannel near-infrared spectroscopy study.
Akashi H; Tsujii N; Mikawa W; Adachi T; Kirime E; Shirakawa O
J Affect Disord; 2015 Mar; 174():165-72. PubMed ID: 25497474
[TBL] [Abstract][Full Text] [Related]
51. Low cerebrospinal fluid transthyretin levels in depression: correlations with suicidal ideation and low serotonin function.
Sullivan GM; Mann JJ; Oquendo MA; Lo ES; Cooper TB; Gorman JM
Biol Psychiatry; 2006 Sep; 60(5):500-6. PubMed ID: 16487493
[TBL] [Abstract][Full Text] [Related]
52. Increased matrix metalloproteinases in cerebrospinal fluids of patients with major depressive disorder and schizophrenia.
Omori W; Hattori K; Kajitani N; Tsuchioka MO; Boku S; Kunugi H; Okamoto Y; Takebayashi M
Int J Neuropsychopharmacol; 2020 Jul; 23(11):713-20. PubMed ID: 32671384
[TBL] [Abstract][Full Text] [Related]
53. Hippocampal volume predicts antidepressant efficacy in depressed patients without incomplete hippocampal inversion.
Colle R; Cury C; Chupin M; Deflesselle E; Hardy P; Nasser G; Falissard B; Ducreux D; Colliot O; Corruble E
Neuroimage Clin; 2016; 12():949-955. PubMed ID: 27995060
[TBL] [Abstract][Full Text] [Related]
54. Reduced Cerebrospinal Fluid Levels of Lysophosphatidic Acid Docosahexaenoic Acid in Patients With Major Depressive Disorder and Schizophrenia.
Omori W; Kano K; Hattori K; Kajitani N; Okada-Tsuchioka M; Boku S; Kunugi H; Aoki J; Takebayashi M
Int J Neuropsychopharmacol; 2021 Dec; 24(12):948-955. PubMed ID: 34214158
[TBL] [Abstract][Full Text] [Related]
55. Treatment enhances ultradian rhythms of CSF monoamine metabolites in patients with major depressive episodes.
Salomon RM; Kennedy JS; Johnson BW; Urbano Blackford J; Schmidt DE; Kwentus J; Gwirtsman HE; Gouda JF; Shiavi RG
Neuropsychopharmacology; 2005 Nov; 30(11):2082-91. PubMed ID: 15856079
[TBL] [Abstract][Full Text] [Related]
56. Dysregulation of IRAS/nischarin and other potential I
Keller B; García-Sevilla JA
J Affect Disord; 2017 Jan; 208():646-652. PubMed ID: 27836117
[TBL] [Abstract][Full Text] [Related]
57. Influence of comorbid alcohol use disorder on treatment response of depressive patients.
Hashimoto E; Tayama M; Ishikawa H; Yamamoto M; Saito T
J Neural Transm (Vienna); 2015 Feb; 122(2):301-6. PubMed ID: 24928545
[TBL] [Abstract][Full Text] [Related]
58. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
59. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
[TBL] [Abstract][Full Text] [Related]
60. Predictors of remission with placebo using an integrated study database from patients with major depressive disorder.
Nelson JC; Zhang Q; Deberdt W; Marangell LB; Karamustafalioglu O; Lipkovich IA
Curr Med Res Opin; 2012 Mar; 28(3):325-34. PubMed ID: 22292447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
